December 2022

Families of Passengers on Missing Rohingya Refugee Boat Keep Hopes Alive

The United Nations refugee agency said Sunday in a statement that about 180 Rohingya were feared to have drowned at sea after their boat left Bangladesh for Malaysia earlier this month. When a boat carrying 174 Rohingya washed ashore Monday in Indonesia, many people speculated that they were the ones the refugee agency had assumed to have drowned. However, some Rohingya in Bangladesh and Malaysia, who managed to speak to the refugees rescued Monday, confirmed that those 174 were not related to the 180 refugees still missing and feared dead. Several people in Malaysia and Cox’s Bazar, Bangladesh — where

Read More

St Kitts and Nevis introduces raft of changes to its Citizenship by Investment Programme, benefits both locals and an intelligent investor

London, Dec. 27, 2022 (GLOBE NEWSWIRE) — The much-anticipated changes to St Kitts and Nevis’ Citizenship by Investment Programme have been announced today by the country’s recently appointed Citizenship by Investment Unit Head, Michael Martin. Setting a bold and new tone for the industry as a whole, St Kitts and Nevis is once again leading […]

Read More

BITPOINT Launches Japanese Weeks for Crypto Users in Latin America

BITPOINT Latam is continuing to expand its services in Latin America, a market that is seeing rapid growth in cryptocurrency adoption. BITPOINT’s executives have stated that their recent focus on the Japanese market is part of their plan to increase education and commercial activity in the cryptocurrency space. Featured Image for BITPOINT Latam MEDELLÍN, Colombia, […]

Read More

China to End Quarantine on Arrival in Fresh COVID Rule Relaxation

China said Monday it would scrap mandatory quarantine on arrival, further unwinding years of strict virus controls as the country battles a surge in cases. Having mostly cut itself off from the rest of the world during the pandemic, China is now experiencing an unprecedented surge in infections after abruptly lifting restrictions that torpedoed the economy and sparked nationwide protests. And in a sudden end to nearly three years of strict border controls, Beijing said late Monday it would scrap mandatory quarantines for overseas travelers. Since March 2020, all passengers arriving in China have had to undergo mandatory centralized quarantine.

Read More

Long COVID: Could Mono Virus or Fat Cells Be Playing Roles?

A British historian, an Italian archaeologist and an American preschool teacher have never met in person, but they share a prominent pandemic bond. Plagued by eerily similar symptoms, the three women are credited with describing, naming and helping bring long COVID into the public’s consciousness in early 2020. Rachel Pope, of Liverpool, took to Twitter in late March 2020 to describe her bedeviling symptoms, then unnamed, after a coronavirus infection. Elisa Perego in Italy first used the term “long COVID,” in a May tweet that year. Amy Watson in Portland, Oregon, got inspiration in naming her Facebook support group from

Read More

Second boatload of Rohingya arrives in Indonesia in as many days

About 185 gaunt and bone-tired Rohingya refugees landed on the coast of Pidie regency in Indonesia’s Aceh province Monday, police said, as reports emerged that another boatload of Rohingya may have sunk at sea.   Two NGOs confirmed to BenarNews that the new arrivals were from a boat that was at sea for about a month and stranded as food and water supplies dwindled. As many as 20 of the passengers perished, NGO sources said, while the refugees journeyed south across the Andaman Sea as they fled refugee camps in Bangladesh. Citing information from refugees, a fisherman in Pidie said they

Read More

Junshi Biosciences and Hikma Sign Exclusive Licensing Agreement for Cancer Treatment Drug Toripalimab for the Middle East and North Africa Region

SHANGHAI, China, Dec. 26, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, today announces a new exclusive licensing and commercialization agreement with Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company, for toripalimab in […]

Read More

Junshi Biosciences and Coherus Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

– FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA – – Junshi Biosciences and Coherus are actively engaged in ongoing discussions with the FDA to support the inspections and gain approval of toripalimab for patients with NPC in the U.S. as quickly […]

Read More

Recent Posts